The American public deserves more COVID-19 vaccine options

Covaxin, an inactivated SARS-CoV-2 vaccine and the only vaccine to have been proven effective against all variants including the Delta variant in a Phase III clinical study, deserves to be tested in clinical trials in the U.S. for potential CDC/FDA approval for use in the U.S. As we are about to celebrate the one-year anniversaryRead more …The American public deserves more COVID-19 vaccine options originally appeared inKevinMD.com.

Source: Kevin, M.D. - Medical Weblog - December 8, 2021 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/blog/post-author/tayson-delengocky" rel="tag" > Tayson DeLengocky, DO < /a > < /span > Tags: Conditions COVID-19 coronavirus Infectious Disease Source Type: blogs